Bone glue is an adhesive that is used to join or fuse broken bones together during orthopedic surgeries or to replace screws and plates. It is a two-component bone-like and rubber-like adhesive made from natural polymers of collagen and hyaluronic acid which are the main components of human bones. The global bone glue market is estimated to be valued at US$ 2,332.0 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
Increasing bone injuries owing to rising sports injuries and accidents is expected to drive the growth of the bone glue market over the forecast period. According to the World Health Organization (WHO), road accidents are the 8th leading cause of death globally, with around 1.35 million people dying each year as a result of road traffic crashes. Around 20-50 million people suffer non-fatal injuries, with many sustaining bone fractures and injuries that require surgical treatment. In addition, participation in sports and recreational activities has witnessed significant growth over the past few years leading to increasing bone injuries that require orthopedic interventions. Bone glue provides surgeons with an effective and technically easier alternative to plates and screws for joining bones during fracture repair procedures. This assists in driving its use in orthopedic surgeries. Additionally, bone glue not only fuses the bones but also enables early wound healing without bone loss making it a favorable option over other bone fixation devices. These advantages make bone glue an ideal option for treating bone fractures thereby augmenting market growth over the forecast period. The second driver can also be the fact that bone glue technology reduces procedure time and risk of infection as it does not require opening the fractured site hence propelling the market growth.

SWOT Analysis
Strength: Bone glue is a minimally invasive alternative to traditional techniques like plating, wiring, and screwing. It adheres bones together quickly and can facilitate earlier weight-bearing. Bone glues bond quickly to facilitate shorter surgical and recovery times.
Weakness: Bone glues have potential limitations. Their adherence may not match traditional fixation techniques in certain fractures or osteotomies requiring prolonged mechanical stability. Regulatory approval is still required for some applications.
Opportunity: The aging population and rising rates of trauma, sports injuries, and bone-related surgeries present opportunities for bone glues. Newer formulations that provide enhanced strength, handling characteristics, or bone regeneration could gain usage in additional procedures.
Threats: Traditional fixation methods still dominate certain high-risk applications due to proven track records. New bone glues must prove equivalent or superior clinical outcomes to displace entrenched competitors. Economic constraints could impede market growth in some regions.

Key Takeaways
The global bone glue market is expected to witness high growth over the forecast period of 2023 to 2030.

Regional analysis shows North America currently dominates due to large healthcare expenditures and rapid adoption of new technologies. However, Asia Pacific is poised to grow at the fastest rate due to expanding medical infrastructures and an enormous patient population.

Key players operating in the bone glue market are Cryolife, Luna Innovations Incorporated., Stryker, Johnson & Johnson, Baxter International Inc., Omrix Biopharmaceuticals Ltd., Integra Lifesciences Holdings Corporation, B. Braun Melsungen AG, and Cardinal Health.Cryolife and Luna Innovations are pioneering advanced formulations while industry leaders like Stryker and J&J combine bone glue portfolios with comprehensive trauma product lines.